Category Archive for Interesting Reads
For opinion pieces and round-ups
World Antimicrobial Awareness week in focus
Every year, the World Health Organisation (WHO) dedicates one week to promoting the correct and responsible use of antimicrobials and … read more »
European Alliance for Value in Health to put value and outcomes at centre of health systems
The newly formed European Alliance for Value in Health represents a group of European associations representing patients, hospitals, the life … read more »
WHO joins forces with ICMRA against COVID-19
In a joint statement, the World Health Organization (WHO) and the International Coalition of Medicines Regulatory Authorities (ICMRA) have pledged … read more »
Testing requirements are likely slowing biosimilar entries in the US
New analysis suggests a high testing bar for biosimilars to gain regulatory approval is another contributing factor for slowing biosimilar … read more »
FDA releases COVID-19 vaccine guidelines
Over the past months as many pharmaceutical companies move towards US Food and Drugs Administration (FDA) license applications for their … read more »
Industry leaders promise social responsibility in new Biotech Social Pact
69 leaders of the biotech and life science industry including CEOs, investors and other stakeholders have signed a pact declaring … read more »
AMA pushes for transparency in coronavirus vaccine effort
The American Medical Association (AMA) has cautioned the US Food and Drug Administration (FDA) to ensure its assessment of vaccines … read more »
Pharma presents drug pricing plans to White House
Reports say that the pharmaceutical industry has presented its own plan to reduce drugs spend in the USA in an … read more »
Reports: China sets-out rules for vaccine approval
China’s National Medical Products Administration (NMPA) has reportedly revealed its criteria for approving COVID-19 vaccines for use. According to Fierce … read more »
USA: Analysis shows States pushing ahead with pricing legislation
A new analysis by Deloitte has shown that States across America have been progressing various forms of drug pricing legislation, … read more »
